Path to Zero Failures in Pharma Manufacturing using AI and Automation
In the pharmaceutical manufacturing sector, batch failures and deviations in Critical Quality Attributes (CQAs) pose substantial risks, leading to significant financial, operational, and reputational damages. These disruptions can affect drug supply, elevate drug costs, and, most critically, endanger human lives. Hence, both pharmaceutical companies and regulatory agencies such as the FDA and EMA are dedicated to eradicating production failures to ensure public health and uphold the industry's integrity.